HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of a Shuangling Fuzheng anticancer preparation on the proliferation of SGC-7901 cells and immune function in a cyclophosphamide-treated murine model.

AbstractAIM:
To study the inhibitory effects of a Shuangling Fuzheng anticancer preparation (SFAP) on the human gastric cancer cell line SGC-7901 in vitro as well as its immune-modulated effects in a cyclophosphamide-treated murine model.
METHODS:
MTT experiments and immunocytochemistry ABC experiments were performed for detecting the proliferation of SGC-7901 cells in vitro and protein expression of c-myc. The staphylococcal protein A (SPA) rosette test was utilized for measuring the ratio of T-lymphocyte subsets from peripheral blood in a cyclophosphamide-treated murine model. Enzyme-linked immunosorbant assay (ELISA) was performed for measuring the levels of serum sIL-2R in treated mice, while immunoturbidimetry was used for measuring the levels of immunoglobulins (Ig).
RESULTS:
SFAP (40-640 mg/L, 48 h) inhibited the proliferation of SGC-7901 cells, and a positive correlation was noted between inhibitory effects and dosage. At a dosage of 160-320 mg/L in cultured cells, the expression of c-myc was decreased. SFAP (50-200 mg/kg) increased the percentage of CD3+ and CD4+ T-lymphocytes, the ratio of CD4/CD8, and the contents of Ig such as IgM, IgG or IgA, but decreased the levels of serum sIL-2R in peripheral blood from cyclophosphamide-treated mice.
CONCLUSION:
SFAP can inhibit the proliferation of SGC-7901 cells via the c-myc gene. In addition, SFAP can modulat the cellular and humoral immunity in cyclophosphamide-induced immunosuppressed mice.
AuthorsHua-Sheng Chen, Jue Chen, De-Li Cui, Yuan-Yuan Zheng, Ai-Hua Xu, Gang Chen, Ling-Chang Jia
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 13 Issue 48 Pg. 6575-80 (Dec 28 2007) ISSN: 1007-9327 [Print] United States
PMID18161930 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Drugs, Chinese Herbal
  • Immunoglobulins
  • Immunosuppressive Agents
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Receptors, Interleukin-2
  • Shuangling Fuzheng anticancer preparation
  • Cyclophosphamide
Topics
  • Animals
  • Antibody Formation (drug effects)
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Cyclophosphamide (pharmacology)
  • Dose-Response Relationship, Drug
  • Drugs, Chinese Herbal (pharmacology)
  • Female
  • Humans
  • Immunity, Cellular (drug effects)
  • Immunoglobulins (blood)
  • Immunosuppression Therapy
  • Immunosuppressive Agents (pharmacology)
  • Mice
  • Mice, Inbred ICR
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Receptors, Interleukin-2 (blood)
  • Stomach Neoplasms (metabolism, pathology)
  • T-Lymphocyte Subsets (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: